Amirreza Shaabani

Amirreza Shaabani

Auto-generated profile, based on publicly available information

Amirreza Shaabani

Farabi Eye Hospital

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Journal of Current Ophthalmology
Verified
Journal Article
Open access
MMMehrdad Mohammadpour
Mehrdad Mohammadpour
ASAmirreza Shaabani
Amirreza Shaabani
ASAlireza Sahraian
Alireza Sahraian
BMBita Momenaei
Bita Momenaei
FTFereshteh Tayebi
Fereshteh Tayebi
RMReza Mirshahi
Reza Mirshahi
A comprehensive review in congenital cataract management can guide general ophthalmologists in managing such a difficult situation which remains a significant cause of preventable childhood blindness. This review will focus on surgical management, postoperative complications, and intraocular lens (IOL)-related controversies. Electrical records of PubMed, Medline, Google Scholar, and Web of Science from January 1980 to August 2017 were explored using a combination of keywords: "Congenital", "Pediatric", "Childhood", "Cataract", "Lens opacity", "Management", "Surgery", "Complication", "Visual rehabilitation", and "Lensectomy". A total number of 109 articles were selected for the review process. This review article suggests that lens opacity obscuring the red reflex in preverbal children and visual acuity of less than 20/40 is an absolute indication for lens aspiration. For significant lens opacity that leads to a considerable risk of amblyopia, cataract surgery is recommended at 6 weeks of age for unilateral cataract and between 6 and 8 weeks of age for bilateral cases. The recommended approach in operation is lens aspiration via vitrector and posterior capsulotomy and anterior vitrectomy in children younger than six years, and IOL implantation could be considered in patients older than one year. Most articles suggested hydrophobic foldable acrylic posterior chamber intraocular lens (PCIOL) for pediatrics because of lower postoperative inflammation. Regarding the continuous ocular growth and biometric changes in pediatric patients, under correction of IOL power based on the child's age is an acceptable approach. Considering the effects of early and late postoperative complications on the visual outcome, timely detection, and management are of a pivotal importance. In the end, the main parts of post-operation visual rehabilitation are a refractive correction, treatment of concomitant amblyopia, and bifocal correction for children in school age. The management of congenital cataracts stands to challenge for most surgeons because of visual development and ocular growth. Children undergoing cataract surgery must be followed lifelong for proper management of early and late postoperative complications. IOL implantation for infants less than 1 year is not recommended, and IOL insertion for children older than 2 years with sufficient capsular support is advised.

1 April 2021 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
MFMasoud Aghsaei Fard
Masoud Aghsaei Fard
MSMona Safizadeh
Mona Safizadeh
ASAmirreza Shaabani
Amirreza Shaabani
RKRahele Kafieh
Rahele Kafieh
SHSahar Hojati
Sahar Hojati
SMSasan Moghimi
Sasan Moghimi

1 January 2012 in Journal of Biologically Active Products from Nature
Verified
Journal Article
Closed access
JAJavad Alizargar
Javad Alizargar
EKEbrahim Kuchaki
Ebrahim Kuchaki
ASAmirreza Shaabani
Amirreza Shaabani
MNMansour Namazi
Mansour Namazi
The process of wound healing begins to restore the integrity and normal function of damaged tissue. At the site of injury free radicals are produced. They can make the processes of wound healing slowly. They do this with causing damage to cellular membranes, proteins, nucleotides and lipids. Antioxidants as a therapy, can promote the process of wound healing. Rosemary extract has different antioxidant components. In this study, we evaluated rosemary extract for its possible wound healing properties, when it is used topically in the site of injury. We divided male Wistar rats in 5 groups (n=10/group) and a full-thickness 2cm*2cm skin excision was made. Groups 1–4 were treated with 15 %, 10 % and 5 % of the rosemary extracts in eucerin and comparative treatment (phenytoin 1 % in eucerin) respectively. Group 5 was treated with eucerin as the control group. The substances were applied topically once a daily until re-epithelialization was recorded. Faster wound re-epithelialization was observed in rats treated with 15 %, 10 % and 5 % of the rosemary extracts in eucerin compared with group 5 (eucerin). A significant reduction were observed in wound length and the re-epithelialization rate was faster in Rosemary extract groups, compared with the group 5 (control group) (P<0.05). The re-epithelialization period (time until normal skin replaces the wound) of the group 1–4 was shorter than group 5. (15, 14, 18 compared with 26). The results show that rosemary extract can be developed to a new topical medicine for wound healing.

27 April 2014 in Nephro-Urology Monthly
Verified
Journal Article
Open access
PDF file
MSMohammad Reza Sharif
Mohammad Reza Sharif
ASAmirreza Shaabani
Amirreza Shaabani
HMHossein Mahmoudi
Hossein Mahmoudi
HNHassan Nikoueinejad
Hassan Nikoueinejad
HAHossein Akbari
Hossein Akbari
BEBehzad Einollahi
Behzad Einollahi
Background: Recently, the development of new biomarkers as prognostic and predictive markers in prostate cancer has been crucial. Objectives: This study was aimed to determine whether serum vascular endothelial growth factor (VEGF) levels would be a prognostic marker or risk assessment factor in patients with prostate cancer and to investigate whether it could differentiate cancerous tissue from benign prostate hyperplasia (BPH). Patients and Methods: We enrolled 44 patients with prostate cancer, 57 patients with BPH, and 57 healthy individuals. Serum VEGF levels was measured by ELISA and was compared among all groups; then, its correlation with PSA and Gleason score in cancerous group was assessed. In addition, by using receiver operating characteristic (ROC) curve and area under curve (AUC), we determined the sensitivity and specificity of VEGF as well as combined variable of VEGF and PSA as a diagnostic marker of prostate cancer. Results: Serum VEGF level was significantly higher in patients with prostate cancer in comparison to the other groups (P value < 0.001); however, it was not different between BPH and control groups. Only in cancerous group a significant correlation between VEGF and PSA was found (r = 0.425, P = 0.004). Assessing the risk of prostate cancer, we found a powerful correlation between the VEGF alone as well as the combination of VEGF and PSA with prostate cancer. Conclusions: VEGF may be a diagnostic biomarker of prostate cancer. In addition, it may differentiate the cancerous tissue from BPH. We suggest that VEGF combined with PSA may be used as a screening test of prostate cancer. Keywords: Vascular Endothelial Growth Factor A; Prostatic Neoplasms; BPH

30 April 2021 in Research Square
Verified
Preprint
Open access
PDF file
SAShaabani Amirreza
Shaabani Amirreza
JMJabbarvand Mahmoud
Jabbarvand Mahmoud
SAShahbazi Ahad
Shahbazi Ahad
Purpose: To compare epithelial thickness before and after photorefractive keratectomy (PRK) with and without mitomycin-C (MMC).Methods: Forty eyes treated with PRK for low myopia (less than -4.00 D) and low astigmatism (less than -2.00) were included in this interventional case series. The right eye of each patient assigned to receive intraoperative topical MMC% 0.02 for 15 to 30 seconds and other eye received equally balanced salt solution (control group). Epithelial thickness profile was analyzed before and 6 months postoperatively.Results: Epithelial thickness map was analyzed in superior and inferior of the cornea within central 7 mm diameter. Maximum and minimum thickness was measured and the data were compared before and after PRK. The Superior, the inferior and the maximum epithelial thickness were significantly increased after surgery in both groups (p<0.05). There was no significant difference in epithelial thickness profile between case and control group at baseline and 6-month post PRK. Final distance corrected visual acuity was similar in two groups. No case of corneal haze was observed during 6 months follow up visits.Conclusion: Intraoperative MMC% 0.02 in PRK for low myopia patients did not change the epithelial thickness profile and refractive results, when compared with matched control eyes in 6 months follow up. It seems that MMC doesn’t have a statistically significant impact in epithelial remodeling based on this data set.